Felicia Vonella | Executive Director-Investor Relations |
Ron Cohen | Chief Executive Officer |
Carmen Augustine | JPMorgan |
Kelechi Chikere | Jefferies |
Phil Nadeau | Cowen and Company |
Ross Weinreb | Goldman Sachs |
Laura Chico | Raymond James |
Ben Burnett | Stifel |
Raghuram Selvaraju | H.C. Wainwright |
Silvan Turkcan | Oppenheimer |
Ken Trbovich | Janney |
Welcome to the Acorda Therapeutics Third Quarter 2018 Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer-session to follow. Please be advised that this call is being taped at the company's request. I will now introduce your host for today's call, Felicia Vonella, Executive Director of Investor Relations at Acorda.